<unk>  is an antimetabolite that is FDA approved for the treatment of lymphomatous meningitis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include headache , nausea, vomiting , arachnoiditis, weakness, confusion, pyrexia, fatigue, constipation, back pain, gait abnormal , convulsions , dizziness , lethargy,  insomnia, urinary tract infection , neck pain, dehydration, anemia , diarrhea , appetite decreased , thrombocytopenia, edema peripheral, arthralgia, neck stiffness vision blurred, muscle weakness, neutropenia, hypoesthesia, agitation, and dyspnea.
Cytarabine liposome
Vincristine liposome
Daunorubicin liposome
Daunorubicin / cytarabine
Doxorubicin liposome
Liposomal daunorubicin
Dihydroergocristine
Taxane